Endolymphatic sac tumor (ELST) is a rare, aggressive hypervascular tumor of the posterior petrous bone. These tumors can manifest independently or in conjunction with Von Hippel-Lindau (VHL) syndrome. Currently, the primary treatment strategy involves complete surgical excision, though the role of radiotherapy remains debated.We are reporting a case of a 35-year-old female patient affected by ELST associated with VHL syndrome, managed solely through stereotactic radiosurgery and monitored by time-resolved imaging of contrast kinetics magnetic resonance sequence.

Download full-text PDF

Source
http://dx.doi.org/10.1177/01455613241306962DOI Listing

Publication Analysis

Top Keywords

endolymphatic sac
8
sac tumor
8
time-resolved imaging
8
imaging contrast
8
contrast kinetics
8
vhl syndrome
8
tumor post-radiosurgery
4
post-radiosurgery evaluation
4
evaluation time-resolved
4
kinetics angiography
4

Similar Publications

Microscale Proteomic Analysis of the Endolymphatic Sac in Menière's Disease Patients.

Otol Neurotol

February 2025

Department of Otolaryngology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Objective: Endolymphatic hydrops is the primary pathological feature of Menière's disease (MD). An imbalance between endolymphatic fluid production and absorption due to endolymphatic sac (ES) dysfunction may be the major cause of endolymphatic hydrops. This study aimed to identify and characterize global protein expression of the ES in MD patients using microscale proteomics for the first time.

View Article and Find Full Text PDF

Von Hippel-Lindau syndrome: clinical features, genetic foundations, and management strategies.

Mol Biol Rep

March 2025

Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY, 10461, USA.

Von Hippel-Lindau Syndrome (VHL) is a rare, hereditary disorder characterized by the development of multiple tumors and cysts in various parts of the body due to mutations in the VHL gene on chromosome 3p25-26. Patients with VHL are at increased risk for hemangioblastomas of the brain, spinal cord, and retina, renal cell carcinomas, pheochromocytomas, pancreatic neuroendocrine tumors, and endolymphatic sac tumors. Clinical manifestations vary widely, and early diagnosis through genetic testing and regular surveillance is crucial for effective management.

View Article and Find Full Text PDF

Chinese head and neck pathology has been comprehensively improved in the past ten year. This paper focuses on the observation and research of sinonasal epithelial tumors, non-epithelial tumors, inflammatory diseases, NK/T cell lymphoma, nasopharyngeal carcinoma, oropharyngeal HPV-associated squamous cell carcinoma, laryngeal squamous cell carcinoma, ear neuroendocrine tumor, adenoid cystic carcinoma, endolymphatic sac tumor, and hyperplastic disease of Waldeyer's ring lymphoid tissue, etc. The difficult cases were reviewed.

View Article and Find Full Text PDF

Endolymphatic duct blockage technique should be dictated by a precise anatomical understanding and surgical adaptation. This article focuses on the surgical approaches and anatomical variations of the endolymphatic sac during the transmastoid route, which varies with the size of the duct within the petrous bone and its accessibility. Laryngoscope, 2025.

View Article and Find Full Text PDF

Pendred syndrome and autosomal recessive non-syndromic hearing loss, type 4 (DFNB4), are associated with mutations in SLC26A4 that encodes the anion transporter SLC26A4 (pendrin). SLC26A4 is expressed in mitochondria-rich cells of the endolymphatic sac, spindle and root cells in the cochlear lateral wall, transitional cells in the vestibular organs, follicular cells in the thyroid, and type B intercalated cells in the kidney. This study aimed to assess the gene profiles of murine Slc26a4-expressing cells to better understand the regulatory mechanisms and functions of SLC26A4.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!